Q32 Bio Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Q32 Bio Inc. (QTTB), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are QTTB insiders buying or selling?
In the last 12 months, Q32 Bio Inc. insiders reported 2 open-market purchases ($30.0M) and 8 sales ($459.8K) — net buying of $29.5M. Since April 2018, Trabud has recorded 92 Form 4 filings for QTTB: 8 buys ($82.1M) and 84 sells ($110.1M).
Source: SEC EDGAR Form 4
Key Statistics (April 2018 – Aug 27, 2026)
Total Form 4 filings
92
SEC EDGAR
Insider filers
21
Insider buys (8)
$82.1M
Insider sells (84)
$110.1M
Insider sentiment
Net sellingNet insider flow of $28.1M in net selling since April 2018, and $29.5M in net buying over the last 12 months.
Recent QTTB insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | Jodie Pope Morrison | CEO | Sale | 9.8K | $16.56 | $163.0K | SEC ↗ |
| Aug 27, 2026 | Lee Kalowski | CFO and President | Sale | 4.0K | $16.56 | $65.8K | SEC ↗ |
| Aug 27, 2026 | Shelia M. Violette | Chief Scientific Officer | Sale | 2.8K | $16.56 | $46.3K | SEC ↗ |
| Jun 2, 2026 | Diyong Xu | Director, 10% Owner | Purchase | 1.9M | $8.00 | $15.0M | SEC ↗ |
| Jun 2, 2026 | ORBIMED ADVISORS LLC | Director, 10% Owner | Purchase | 1.9M | $8.00 | $15.0M | SEC ↗ |
| Feb 28, 2026 | Lee Kalowski | CFO and President | Sale | 4.0K | $4.51 | $18.0K | SEC ↗ |
| Feb 28, 2026 | Jodie Pope Morrison | CEO | Sale | 9.9K | $4.51 | $44.7K | SEC ↗ |
| Feb 28, 2026 | Shelia M. Violette | Chief Scientific Officer | Sale | 2.8K | $4.51 | $12.7K | SEC ↗ |
| Dec 5, 2025 | Jodie Pope Morrison | CEO | Sale | 22.5K | $3.46 | $77.9K | SEC ↗ |
| Dec 5, 2025 | Lee Kalowski | CFO and President | Sale | 9.1K | $3.46 | $31.4K | SEC ↗ |
| Aug 28, 2025 | Jodie Pope Morrison | CEO | Sale | 10.5K | $1.80 | $18.9K | SEC ↗ |
| Aug 28, 2025 | Shelia M. Violette | Chief Scientific Officer | Sale | 3.0K | $1.80 | $5.4K | SEC ↗ |
| Aug 28, 2025 | Lee Kalowski | CFO and President | Sale | 4.2K | $1.80 | $7.6K | SEC ↗ |
| Aug 14, 2024 | Arthur Tzianabos | Director | Sale | 265 | $24.20 | $6.4K | SEC ↗ |
| Apr 23, 2024 | Paul Alloway | Former President and Chief Operating Officer of Homology Medicines, Inc. | Sale | 268 | $24.21 | $6.5K | SEC ↗ |
| Apr 23, 2024 | Charles Michaud Jr | Former Vice President, Corporate Controller and Treasurer of Homology Medicines, Inc. | Sale | 75 | $24.20 | $1.8K | SEC ↗ |
| Feb 15, 2024 | Arthur Tzianabos | Director | Sale | 13.0K | $0.57 | $7.4K | SEC ↗ |
| Jan 5, 2024 | Paul Alloway | President and Chief Operating Officer | Sale | 7.3K | $0.57 | $4.1K | SEC ↗ |
| Jan 5, 2024 | Charles Michaud Jr | Vice President, Corporate Controller and Treasurer | Sale | 1.7K | $0.57 | $975.27 | SEC ↗ |
| Sep 8, 2023 | Albert Seymour | President and Chief Executive Officer | Sale | 1.4K | $1.15 | $1.7K | SEC ↗ |
| Aug 8, 2023 | Julie Jordan | Chief Medical Officer | Sale | 1.9K | $1.39 | $2.6K | SEC ↗ |
| Aug 4, 2023 | Julie Jordan | Chief Medical Officer | Sale | 99 | $1.31 | $129.69 | SEC ↗ |
| Mar 6, 2023 | Paul Alloway | Chief Legal Officer and Secretary | Sale | 11.0K | $1.45 | $15.9K | SEC ↗ |
| Jan 11, 2023 | Michael Lee Blum | Chief Commercial Officer | Sale | 2.5K | $1.39 | $3.4K | SEC ↗ |
| Jan 11, 2023 | Paul Alloway | Chief Legal Officer and Secretary | Sale | 3.1K | $1.39 | $4.3K | SEC ↗ |
Showing the 25 most recent of 92 Form 4 filings for Q32 Bio Inc..
Most active QTTB insiders
- Albert Seymour12 filings
- Arthur Tzianabos12 filings
- Bradford W Smith11 filings
- Timothy P Kelly11 filings
- 5AM Ventures IV, L.P.6 filings
Ask anything about QTTB insider activity
Use Trabud's AI agent to query Q32 Bio Inc.'s Form 4 history in plain English — "Show me QTTB CEO purchases this year" or compare it against any other ticker.
Open the AI agentQTTB insider trading FAQ
Are Q32 Bio Inc. insiders buying or selling?
In the last 12 months, Q32 Bio Inc. insiders reported 2 open-market purchases ($30.0M) and 8 sales ($459.8K) — net buying of $29.5M. Since April 2018, Trabud has recorded 92 Form 4 filings for QTTB: 8 buys ($82.1M) and 84 sells ($110.1M). Over the full record that is net selling of $28.1M.
How many insiders trade QTTB stock?
21 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Q32 Bio Inc.. The most recent filing was accepted on Aug 27, 2026.
Where does Trabud get QTTB insider trading data?
All QTTB insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.